Stock Analiz

CONMED Corp (CNMD) stock forecast and price target

Price $50.59 · data as of November 13, 2026

12-month price target

Average target$46.83
Upside / downside−7.4%
Analysts6
ConsensusHold
Low $43.00Average $46.83High $50.00

Gold marker: average target · white marker: today’s price ($50.59)

Analyst ratings

Strong buy 0Buy 0Hold 6Sell 0Strong sell 1

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$4.57−0.4%$1.4B
Next fiscal year
ends December 31, 2027
$4.75+3.9%$1.4B
Next quarter
ends December 31, 2026
$1.26−11.6%$367M
Quarter after
ends March 31, 2027
$0.98+10.1%$329M

Consensus of the analysts covering CONMED, updated daily. In the last 30 days 6 estimates were raised and 0 lowered.

Our model vs. Wall Street

Analysts see 7.4% downside over 12 months. Our discounted cash flow model with moderate assumptions puts CONMED’s intrinsic value about 5% below today’s market value, and it scores 2.4 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.

Frequently asked questions

What is the CONMED stock price target?

The average 12-month target from 6 analysts is $46.83, 7.4% below the current price of $50.59 Targets range from $43.00 to $50.00.

Is CONMED a buy according to analysts?

The consensus rating is “Hold” (6 hold, 1 strong sell). Ratings are opinions, not guarantees; this is not investment advice.

How much is CONMED expected to earn?

Analysts expect EPS of $4.57 for the fiscal year ending December 31, 2026 and $4.75 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.